Answers are grounded in this paper and cite their sources.
Transcatheter aortic valve replacement (TAVR) is indicated for severe aortic stenosis patients with a prohibitive surgical risk. However, its use has been expanding in recent years to include intermediate- and low-risk patients. Thus, registry data describing changes in patient characteristics and outcomes are needed. The aim of this study was to analyse the temporal changes in patient profiles and clinical outcomes of all-comer TAVR.
No takes yet. Share an insight, caveat, or question.
Karra et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: